Sheree R Schwartz1, Jean Bassett2, Lillian Mutunga2, Nompumelelo Yende3, Mutsa Mudavanhu2, Rebecca Phofa3, Ian Sanne4, Annelies Van Rie5. 1. Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA. Electronic address: sschwartz@jhu.edu. 2. Witkoppen Health and Welfare Centre, Johannesburg, South Africa. 3. Witkoppen Health and Welfare Centre, Johannesburg, South Africa; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa. 4. Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa; Right to Care, Johannesburg, South Africa. 5. Department of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium.
Abstract
BACKGROUND: Safer conception strategies empower individuals trying to conceive to minimise HIV transmission risk to partners and potential children; however, effectiveness data are scarce. We aimed to assess adoption of safer conception methods and HIV and pregnancy outcomes from Sakh'umndeni, a novel safer conception service in South Africa. METHODS: In this prospective cohort study, the Sakh'umndeni clinical cohort at Witkoppen Cinic in Johannesburg (South Africa) enrolled adults aged at least 18 years who were trying to conceive and in relationships with an HIV-positive partner. Couples who were pregnant at enrolment or had been previously diagnosed as infertile were excluded. Participants received safer conception care by a nurse, including antiretroviral therapy (ART) for HIV-positive partners, pre-exposure prophylaxis (PrEP) for HIV-negative partners, counselling around timed condomless sex, or syringes for self-insemination. Primary outcomes were pregnancy incidence and HIV transmission to partners and infants. We estimated time to first pregnancy using Kaplan-Meier curves; pregnancy and HIV incidence were estimated as events per person-years of risk. FINDINGS: Between July 16, 2013, and April 5, 2017, 526 individuals (334 women and 192 men) from 334 partnerships enrolled. 162 (48%) of 334 couples were serodifferent, 149 (45%) were HIV-positive seroconcordant, and 23 (7%) were an HIV-positive woman and an unknown status male partner. At enrolment, 176 (61%) of 287 HIV-positive women and 60 (46%) of 131 HIV-positive men were virally suppressed (<50 copies per mL). Among the safer conception strategies, ART was initiated by 73 (91%) of 80 HIV-positive participants not on ART and PrEP was initiated by 28 (28%) of 101 HIV-negative participants. 2719 follow-up visits were completed, and 99 pregnancies were observed in 89 women. Pregnancy incidence was 41·2 per 100 person-years (95% CI 33·4-50·7); 25 (28%) of 89 pregnancies with a known outcome were miscarried or terminated because of risk to the mother. Pregnancy incidence was 79·0 per 100 person-years (95% CI 49·8-125·4) among HIV-negative women and 36·7 per 100 person-years (29·1-46·3) among HIV-positive women. At the time of pregnancy, viral suppression among women was high (68 [87%] of 78 women had viral loads of <50 copies per mL and 77 [99%] had viral loads of <1000 copies per mL). No horizontal or vertical HIV transmission events were observed. INTERPRETATION: Safer conception strategies empowered couples to safely conceive. Pregnancy incidence among service users was high. Integration of safer conception counselling could promote HIV prevention and linkage to care. FUNDING: US Agency for International Development; UJMT Consortium/Fogarty International Center, US National Institutes of Health (NIH); and Johns Hopkins University Center for AIDS Research (NIH).
BACKGROUND: Safer conception strategies empower individuals trying to conceive to minimise HIV transmission risk to partners and potential children; however, effectiveness data are scarce. We aimed to assess adoption of safer conception methods and HIV and pregnancy outcomes from Sakh'umndeni, a novel safer conception service in South Africa. METHODS: In this prospective cohort study, the Sakh'umndeni clinical cohort at Witkoppen Cinic in Johannesburg (South Africa) enrolled adults aged at least 18 years who were trying to conceive and in relationships with an HIV-positive partner. Couples who were pregnant at enrolment or had been previously diagnosed as infertile were excluded. Participants received safer conception care by a nurse, including antiretroviral therapy (ART) for HIV-positive partners, pre-exposure prophylaxis (PrEP) for HIV-negative partners, counselling around timed condomless sex, or syringes for self-insemination. Primary outcomes were pregnancy incidence and HIV transmission to partners and infants. We estimated time to first pregnancy using Kaplan-Meier curves; pregnancy and HIV incidence were estimated as events per person-years of risk. FINDINGS: Between July 16, 2013, and April 5, 2017, 526 individuals (334 women and 192 men) from 334 partnerships enrolled. 162 (48%) of 334 couples were serodifferent, 149 (45%) were HIV-positive seroconcordant, and 23 (7%) were an HIV-positive woman and an unknown status male partner. At enrolment, 176 (61%) of 287 HIV-positive women and 60 (46%) of 131 HIV-positive men were virally suppressed (<50 copies per mL). Among the safer conception strategies, ART was initiated by 73 (91%) of 80 HIV-positive participants not on ART and PrEP was initiated by 28 (28%) of 101 HIV-negative participants. 2719 follow-up visits were completed, and 99 pregnancies were observed in 89 women. Pregnancy incidence was 41·2 per 100 person-years (95% CI 33·4-50·7); 25 (28%) of 89 pregnancies with a known outcome were miscarried or terminated because of risk to the mother. Pregnancy incidence was 79·0 per 100 person-years (95% CI 49·8-125·4) among HIV-negative women and 36·7 per 100 person-years (29·1-46·3) among HIV-positive women. At the time of pregnancy, viral suppression among women was high (68 [87%] of 78 women had viral loads of <50 copies per mL and 77 [99%] had viral loads of <1000 copies per mL). No horizontal or vertical HIV transmission events were observed. INTERPRETATION: Safer conception strategies empowered couples to safely conceive. Pregnancy incidence among service users was high. Integration of safer conception counselling could promote HIV prevention and linkage to care. FUNDING: US Agency for International Development; UJMT Consortium/Fogarty International Center, US National Institutes of Health (NIH); and Johns Hopkins University Center for AIDS Research (NIH).
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Kenneth Ngure; Renee Heffron; Nelly R Mugo; Connie Celum; Craig R Cohen; Josephine Odoyo; Helen Rees; James N Kiarie; Edwin Were; Jared M Baeten Journal: AIDS Date: 2012-02-20 Impact factor: 4.177
Authors: Pablo Barreiro; Jorge del Romero; Manuel Leal; Victoria Hernando; Román Asencio; Carmen de Mendoza; Pablo Labarga; Marina Núñez; José Tomás Ramos; Juan González-Lahoz; Vincent Soriano Journal: J Acquir Immune Defic Syndr Date: 2006-11-01 Impact factor: 3.731
Authors: Sarah A Gutin; Gary W Harper; K Rivet Amico; Christina Bitsang; Neo Moshashane; Jane Harries; Doreen Ramogola-Masire; Chelsea Morroni Journal: Glob Public Health Date: 2020-03-16
Authors: Yasaman Zia; Jennifer Velloza; Lynda Oluoch; Richard Momanyi; Sarah Mbugua; John Njoroge; Stephen Gakuo; Edwin Mugo; Nicholas Thuo; Catherine Kiptinness; Njambi Njuguna; Kenneth Ngure; Nelly R Mugo; Renee Heffron Journal: Reprod Health Date: 2021-04-01 Impact factor: 3.223
Authors: Lynn T Matthews; Letitia Greener; Hazar Khidir; Christina Psaros; Abigail Harrison; F Nzwakie Mosery; Mxolisi Mathenjwa; Kasey O'Neil; Cecilia Milford; Steven A Safren; David R Bangsberg; Jennifer A Smit Journal: PLoS One Date: 2021-03-25 Impact factor: 3.240
Authors: Cynthia R Young; Elizabeth Gill; Mwebesa Bwana; Winnie Muyindike; Rebecca S Hock; Madeline C Pratt; Moran Owembabazi; Deogratius Tukwasibwe; Alice Najjuma; Paul Kalyebara; Silvia Natukunda; Angela Kaida; Lynn T Matthews Journal: AIDS Behav Date: 2021-06-21
Authors: Elizabeth T Knippler; Rimel N Mwamba; Jessica N Coleman; Brandon A Knettel; Linda M Minja; Godfrey A Kisigo; James S Ngocho; Cody Cichowitz; Blandina T Mmbaga; Melissa H Watt Journal: AIDS Behav Date: 2021-06-14
Authors: Sarah A Gutin; Gary W Harper; Neo Moshashane; Christina Bitsang; Jane Harries; Doreen Ramogola-Masire; Chelsea Morroni Journal: Front Glob Womens Health Date: 2020-12-15